China Resources Medical Holdings マネジメント
マネジメント 基準チェック /04
現在、CEO に関する十分な情報がありません。
主要情報
Hai Yu
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | 1.8yrs |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 1.8yrs |
| 取締役会の平均在任期間 | 2.5yrs |
経営陣の近況
Recent updates
Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher
Oct 02
We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings
May 06China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet
Apr 26Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price
Mar 09Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?
Nov 29China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall
Oct 19Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher
Aug 30Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?
Aug 26China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet
Jun 30China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around
May 12Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)
Apr 03Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Feb 21China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital
Jan 10We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease
Nov 30Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?
Oct 18China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends
Sep 21Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?
Jul 13Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Jun 24China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12
Jun 03China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12
Apr 27We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease
Apr 22Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%
Mar 30Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?
Jan 27China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jan 03China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around
Nov 19Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Oct 26An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued
Sep 20Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly
Sep 06China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively
Aug 17Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher
Jun 21China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate
Jun 09Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality
May 03China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?
Apr 22We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt
Mar 27Should You Be Impressed By China Resources Medical Holdings' (HKG:1515) Returns on Capital?
Mar 12CEO（最高経営責任者
Hai Yu (56 yo)
1.8yrs
在職期間
Mr. Hai Yu is Chief Executive Officer & Executive Director of China Resources Medical Holdings Company Limited from February 27, 2023. He is the general manager of China Resources Health Group Limited, and...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| VP & Executive Director | 2.9yrs | CN¥3.24m | データなし | |
| Executive Chairman of the Board | 6.3yrs | CN¥71.00k | 0.031% HK$ 1.6m | |
| CEO & Executive Director | 1.8yrs | データなし | データなし | |
| CFO & Executive Director | 1.4yrs | データなし | データなし | |
| Company Secretary | less than a year | データなし | データなし |
1.8yrs
平均在職期間
53yo
平均年齢
経験豊富な経営陣: 1515の経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| VP & Executive Director | 3.3yrs | CN¥3.24m | データなし | |
| Executive Chairman of the Board | 6.3yrs | CN¥71.00k | 0.031% HK$ 1.6m | |
| CEO & Executive Director | 1.8yrs | データなし | データなし | |
| CFO & Executive Director | 1.4yrs | データなし | データなし | |
| Honorary Chairman | 8yrs | データなし | データなし | |
| Independent Non-Executive Director | 1.8yrs | データなし | データなし | |
| Independent Non-Executive Director | 6.3yrs | CN¥257.00k | 0% HK$ 0 | |
| Independent Non-Executive Director | 11.2yrs | CN¥257.00k | データなし | |
| Non-Executive Director | 1.2yrs | データなし | 0.0051% HK$ 271.3k | |
| Independent Non-Executive Director | 1.2yrs | CN¥81.00k | データなし |
2.5yrs
平均在職期間
57yo
平均年齢
経験豊富なボード: 1515の 取締役会 は 経験豊富 ではない ( 2.5年の平均在任期間) ため、新しい取締役会が必要であると考えられます。